- Abstract Number: 0561
CD8 T-Cell Expansion May Compensate for Natural Killer Cell Dysfunction in Mice with Chronic Excess IL-18
- Abstract Number: 1192
Celiac Disease in Patients with Systemic Lupus Erythematosus: An Analysis of Nationwide Inpatient Sample
- Abstract Number: 0873
Celiac-Associated Arthritis: Clinical Features, Treatment, and Outcomes
- Abstract Number: 2186
Cellular and Humoral Responses Following SARS-CoV-2 mRNA Vaccination in Patients on PD-1 Immunotherapy with irAEs
- Abstract Number: 1174
Cellular Immunotherapy for Systemic Sclerosis
- Abstract Number: 0602
Cellworks Biosimulation Model (CBM) for Rheumatoid Arthritis (RA), Accurately Captures Patient’s Disease Activity at the Molecular Level Using Their Omics Data and Can Bring Personalization to Treatment Selection in RA
- Abstract Number: 0047
Cenerimod, a Novel Selective S1P1 Receptor Modulator, Prevents or Attenuates Joint Inflammation in Several Preclinical Models of Rheumatoid Arthritis
- Abstract Number: 0363
Centrally-Acting Angiotensin Converting Enzyme Inhibitor (cACEi) and Angiotensin Receptor Blocker (cARB) Use and Cognitive Dysfunction in Patients with Systemic Lupus
- Abstract Number: 0088
Challenges in the Management of Psoriatic Arthritis in Latin America: A Systematic Review
- Abstract Number: 1418
Change in Disease Activity and Occurrence of Adverse Events After Initiation of Etanercept in Pediatric Patients with Juvenile Psoriatic Arthritis in the CARRA Registry
- Abstract Number: 0855
Change in Short Term Outcomes Following Tolerated Disease Activity Level for Individuals with Juvenile Idiopathic Arthritis in the Childhood Arthritis and Rheumatology Research Alliance Registry
- Abstract Number: 0536
Change in Urinary Biomarkers at Three Months Predicts 1-year Treatment Response of Lupus Nephritis Better Than Proteinuria
- Abstract Number: 0380
Changes in Disease Activity and Patient-Reported Outcomes in Psoriatic Arthritis Patients Treated with Ixekizumab in a Real-World US Cohort
- Abstract Number: 0163
Changes in Juvenile Dermatomyositis After the COVID-19 Pandemic
- Abstract Number: 1993
Changes in Omega-6- and Omega-3-Derived Bioactive Lipids in Response to an Anti-Inflammatory Dietary Intervention
- « Previous Page
- 1
- …
- 22
- 23
- 24
- 25
- 26
- …
- 154
- Next Page »